FINCREZO 2.275 mg/ml, solution as a cutaneous spray bottle, 18 ml
Active ingredients: Finasteride
Commercialized according to BDPMDispensing in France: Prescription only
Solution for sprayingbottle, 18 mlcutanée
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- FINCREZO 2,275 mg/mL, solution pour pulvérisation cutanée
- Pharmaceutical form
- solution pour pulvérisation
- Route of administration
- cutanée
- Presentation description
- 1 flacon polypropylène de 18 mL (180 pulvérisations) avec une pompe munie d’un pulvérisateur en polypropylène et un applicateur (polypropylène)
- Marketing authorisation holder
- LABORATOIRES BAILLEUL (LUXEMBOURG)
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 3 Mar 2025
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
61798869CIP73029296CIP133400930292969Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| FINASTÉRIDEsolution | 2,275 mg · 1 mL de solution | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.